Cost-effectiveness of PD-1 inhibitors combined with chemotherapy for first-line treatment of oesophageal squamous cell carcinoma in China: a comprehensive analysis by Kai Xu, Man Yu, Qingli Sun, Lingli Zhang, Xiaodan Qian, Dan Su, Jinhong Gong, Jingjing Shang, Yingtao Lin, Xin Li

Get full text

Efficacy and safety of cadonilimab combined with chemotherapy as the first-line treatment for primary advanced or recurrent endometrial cancer: a prospective single-arm open-label... by Bin Liu, Yu Jiang, Yang Sun, Jie Lin, Jian Chen, Lijun Chen, Linlin Yang, Xiaoxiang Chen, Yuzhi Li, Tongyu Liu, Yingtao Lin, Yanhong Zhuo, Chunhua Tu, Jianping Zou

Get full text

Real-world data of cadonilimab in recurrent or metastatic cervical cancer in China: a multicentric study by Jian Chen, Haijuan Yu, Yingtao Lin, Dan Hu, Li Liu, Renliang Fan, Jianping Zou, Lele Zang, Yao Lin, Rong Lin, Dezhao Chen, Xiaoying Weng, Fenfang Shen, Shaoyu Wang, Wei Zeng, Qihua Tian, Yun Yi, Yuanfeng Chen, Jinjin Miao, Bo Zhang, Yinxia Zou, Fengming Gao, Fengming Gao, Rong Lian, Lin Yang, Yang Sun

Get full text